Search - tctmd.com

Displaying 321 - 340 of 347

Sort: Relevancy | Date

News Daily News

Graft Infection After TEVAR or EVAR a Rare But Serious Complication

Jason Kahn

July 26, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

Caitlin E. Cox

May 13, 2013

News Daily News

Hybrid Coronary Revascularization Shows Promise for High-Risk Patients

Yael L. Maxwell

April 26, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Industry News

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

January 17, 2013

News Daily News

Transcatheter Pulmonary Valve-in-Valve Procedure Possible in Failed Bioprosthesis

December 10, 2012

News Daily News

Model Shows Cost-Effectiveness of Renal Denervation in Men, Women

L.A. McKeown

December 02, 2012

News Conference News AHA 2012

ASCERT: CABG More Cost-Effective Than PCI Over Long Term

Jason Kahn

November 05, 2012

News Industry News

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

October 25, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

News Industry News

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

September 12, 2012

News Industry News

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

August 08, 2012

News Daily News

AAA Screening Good for Men but Rescreening May Be Even Better

L.A. McKeown

July 09, 2012

News Daily News

Rivaroxaban May be Cost-Effective for A-fib Patients

L.A. McKeown

June 06, 2012

News Daily News

CMS Agrees to Cover TAVR for FDA-Approved Use

Caitlin E. Cox

May 07, 2012

News Daily News

Societies Recommend TAVR Program Requirements

L.A. McKeown

March 06, 2012

News Daily News

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

L.A. McKeown

March 05, 2012

Advertisement

Graft Infection After TEVAR or EVAR a Rare But Serious Complication

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

Hybrid Coronary Revascularization Shows Promise for High-Risk Patients

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

Transcatheter Pulmonary Valve-in-Valve Procedure Possible in Failed Bioprosthesis

Model Shows Cost-Effectiveness of Renal Denervation in Men, Women

ASCERT: CABG More Cost-Effective Than PCI Over Long Term

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

AAA Screening Good for Men but Rescreening May Be Even Better

Rivaroxaban May be Cost-Effective for A-fib Patients

CMS Agrees to Cover TAVR for FDA-Approved Use

Societies Recommend TAVR Program Requirements

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content